Interventional device firm Cook Medical said it has received U.S. Food and Drug Administration (FDA) clearance to begin a phase I clinical trial for the evaluation of its Zenith Dissection endovascular stent system.
The trial, which will evaluate the system for the treatment of type B thoracic aortic dissections, will include 15 subjects at Thomas Jefferson University Hospital in Philadelphia, the University of Florida in Gainesville, and Massachusetts General Hospital in Boston, according to Cook of Bloomington, IN.
By AuntMinnie.com staff writers
September 24, 2007
Related Reading
Cook expands existing Cardica deal, September 20, 2007
Cook plans manufacturing expansion, September 18, 2007
Cook debuts SonoBiopsy catheter, August 6, 2007
Cook launches new catheter, June 4, 2007
Cook names new executives, January 23, 2007
Copyright © 2007 AuntMinnie.com
